232 related articles for article (PubMed ID: 23184227)
1. Effect of pH and excipients on structure, dynamics, and long-term stability of a model IgG1 monoclonal antibody upon freeze-drying.
Park J; Nagapudi K; Vergara C; Ramachander R; Laurence JS; Krishnan S
Pharm Res; 2013 Apr; 30(4):968-84. PubMed ID: 23184227
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix?
Chang L; Shepherd D; Sun J; Ouellette D; Grant KL; Tang XC; Pikal MJ
J Pharm Sci; 2005 Jul; 94(7):1427-44. PubMed ID: 15920775
[TBL] [Abstract][Full Text] [Related]
3. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
Schüle S; Friess W; Bechtold-Peters K; Garidel P
Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
[TBL] [Abstract][Full Text] [Related]
4. Probing the Conformation of an IgG1 Monoclonal Antibody in Lyophilized Solids Using Solid-State Hydrogen-Deuterium Exchange with Mass Spectrometric Analysis (ssHDX-MS).
Moussa EM; Singh SK; Kimmel M; Nema S; Topp EM
Mol Pharm; 2018 Feb; 15(2):356-368. PubMed ID: 29355022
[TBL] [Abstract][Full Text] [Related]
5. The formation and effect of mannitol hemihydrate on the stability of monoclonal antibody in the lyophilized state.
Anko M; Bjelošević M; Planinšek O; Trstenjak U; Logar M; Ahlin Grabnar P; Brus B
Int J Pharm; 2019 Jun; 564():106-116. PubMed ID: 30999044
[TBL] [Abstract][Full Text] [Related]
6. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): stability of a monoclonal antibody.
Abdul-Fattah AM; Truong-Le V; Yee L; Nguyen L; Kalonia DS; Cicerone MT; Pikal MJ
J Pharm Sci; 2007 Aug; 96(8):1983-2008. PubMed ID: 17286290
[TBL] [Abstract][Full Text] [Related]
7. Excipients for Room Temperature Stable Freeze-Dried Monoclonal Antibody Formulations.
Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
J Pharm Sci; 2020 Jan; 109(1):807-817. PubMed ID: 31622600
[TBL] [Abstract][Full Text] [Related]
8. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA
Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267
[TBL] [Abstract][Full Text] [Related]
9. Structure, stability, and mobility of a lyophilized IgG1 monoclonal antibody as determined using second-derivative infrared spectroscopy.
Murphy BM; Zhang N; Payne RW; Davis JM; Abdul-Fattah AM; Matsuura JE; Herman AC; Manning MC
J Pharm Sci; 2012 Jan; 101(1):81-91. PubMed ID: 21918984
[TBL] [Abstract][Full Text] [Related]
10. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
[TBL] [Abstract][Full Text] [Related]
11. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Predictors of Protein Relative Stability Obtained by Solid-State Hydrogen/Deuterium Exchange Monitored by FTIR.
Fang R; Obeidat W; Pikal MJ; Bogner RH
Pharm Res; 2020 Aug; 37(9):168. PubMed ID: 32794130
[TBL] [Abstract][Full Text] [Related]
13. Stability of lyophilized sucrose formulations of an IgG1: subvisible particle formation.
Davis JM; Zhang N; Payne RW; Murphy BM; Abdul-Fattah AM; Matsuura JE; Herman AC; Manning MC
Pharm Dev Technol; 2013; 18(4):883-96. PubMed ID: 22813478
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of Controlled Ice Nucleation Techniques for Freeze-Drying of a Therapeutic Antibody.
Gitter JH; Geidobler R; Presser I; Winter G
J Pharm Sci; 2018 Nov; 107(11):2748-2754. PubMed ID: 30055225
[TBL] [Abstract][Full Text] [Related]
15. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
[TBL] [Abstract][Full Text] [Related]
16. The effect of mannitol crystallization in mannitol-sucrose systems on LDH stability during freeze-drying.
Al-Hussein A; Gieseler H
J Pharm Sci; 2012 Jul; 101(7):2534-44. PubMed ID: 22535541
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress.
Telikepalli S; Kumru OS; Kim JH; Joshi SB; O'Berry KB; Blake-Haskins AW; Perkins MD; Middaugh CR; Volkin DB
J Pharm Sci; 2015 Feb; 104(2):495-507. PubMed ID: 25522000
[TBL] [Abstract][Full Text] [Related]
18. Effect of sorbitol and residual moisture on the stability of lyophilized antibodies: Implications for the mechanism of protein stabilization in the solid state.
Chang LL; Shepherd D; Sun J; Tang XC; Pikal MJ
J Pharm Sci; 2005 Jul; 94(7):1445-55. PubMed ID: 15920766
[TBL] [Abstract][Full Text] [Related]
19. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates.
Horn J; Schanda J; Friess W
Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899
[TBL] [Abstract][Full Text] [Related]
20. Impact of bulking agents on the stability of a lyophilized monoclonal antibody.
Meyer JD; Nayar R; Manning MC
Eur J Pharm Sci; 2009 Aug; 38(1):29-38. PubMed ID: 19467324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
